What is the current stock price of Nemaura Medical Inc. (NMRD)?

As of the latest market data, Nemaura Medical Inc. (NMRD) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Nemaura Medical Inc. (NMRD) pay a dividend?

Based on current data, Nemaura Medical Inc. does not have a confirmed active dividend policy.

What is the market cap of Nemaura Medical Inc.?

The current market capitalization of Nemaura Medical Inc. (NMRD) is approximately unavailable.

NMRD

Nemaura Medical Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

NMRD NEWS

defenseworld.net

Mar 9

Reviewing InfuSystem (NYSE:INFU) and Nemaura Medical (OTCMKTS:NMRD)

InfuSystem (NYSE: INFU - Get Free Report) and Nemaura Medical (OTCMKTS:NMRD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Profitability This table compares InfuSystem and Nemaura Medical's net

Company Profile

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2018-02-05

Beta

0.92

Websitenemauramedical.com↗